论文部分内容阅读
Since the middle of 1990s autologous stem cell transplantation has been the cornerstone for the treatment of young patients with multiple myeloma(MM).In the last decade the introduction of novel agents such as immunomodulatory drugs(IMiDs)and proteasome i